SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Nancy M. Schlichting received an automatic grant of 39 restricted stock units (RSUs) tied to a dividend payment. These RSUs were credited on April 15, 2026 in connection with Encompass Health’s common stock dividend of $0.19 per share.
The RSU credit was calculated based on the number of RSUs already in the director’s account, the per share dividend, and the closing stock price of $105.24 on the dividend payment date. After this award, Schlichting directly holds 21,298 shares of Encompass Health common stock. This is a routine, non-cash compensation-related accrual rather than an open-market stock purchase or sale.
Williams Terrance reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Terrance Williams received 27 restricted stock units (RSUs) as a grant tied to a dividend payment. These RSUs were credited on April 15, 2026, when the company paid a $0.19 per share dividend and the stock closed at $105.24. After this award, Williams directly holds a total of 15,196 shares/RSUs of Encompass Health common stock. The transaction reflects a compensation-related RSU credit rather than an open-market stock purchase.
Encompass Health Corporation is asking stockholders to vote at its 2026 annual meeting, which will be held virtually on May 7, 2026 at 11:00 a.m. central time. Holders of common stock as of March 9, 2026 may participate and vote online using a 16-digit control number.
Stockholders are being asked to elect 10 directors for one-year terms, ratify PricewaterhouseCoopers LLP as independent auditor, and approve on an advisory basis executive compensation. The board highlights a long-running pay-for-performance program, strong governance practices, and prior say-on-pay support above 93%, including 97.6% approval in 2025.
Encompass Health Corp ownership disclosure: The Vanguard Group filed an amendment to its Schedule 13G stating it beneficially owns 0 shares of Encompass Health Corp common stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries/divisions to report separately.
Encompass Health Corporation entered a new credit agreement on March 9, 2026, establishing a $1 billion revolving credit facility with a maturity of March 9, 2031. The facility includes a $260 million letter of credit subfacility and a swingline loan sublimit increased to $40 million.
The company used $250.0 million of borrowings and $53.6 million of letters of credit under the new facility to repay and retire all remaining obligations under its prior 2022 credit agreement, which was terminated along with its related collateral and guarantee agreement.
The new agreement keeps terms substantially similar but lowers the undrawn commitment fee by 5 basis points, eliminates a 0.10% Term SOFR interest adjustment, relaxes certain investment, debt, lien, and restricted payment limits, and adds an accordion feature allowing additional term loans or increased revolving commitments, subject to leverage and coverage covenants.
Encompass Health Corp senior vice president and treasurer Edmund Fay reported an open-market sale and a charitable gift of company stock. On March 9, 2026, he sold 11,937 shares of Encompass Health common stock at $107 per share, then donated 3,000 shares as a bona fide gift to a donor advised fund administered by Schwab. After these transactions, Fay directly holds 86,325 shares of Encompass Health common stock, indicating he retains a substantial equity stake in the company.
Encompass Health Corp Chief Accounting Officer handles tax withholding via share disposition
Encompass Health Corp executive Andrew L. Price reported a tax-withholding disposition of 307 shares of Encompass Health common stock on this Form 4. The shares, valued at $107.88 each, were withheld or surrendered to cover tax obligations from vesting restricted stock, not sold in an open‑market trade.
After this transaction, Price directly holds 74,694 shares of Encompass Health common stock.
Encompass Health Corp senior vice president and treasurer Edmund Fay reported a small share disposition related to tax withholding. On the transaction date, 280 shares of Encompass Health common stock were withheld at $107.88 per share to cover tax obligations from vesting restricted stock. After this tax-withholding disposition, Fay directly owned 101,262 shares of Encompass Health common stock.
Encompass Health Corp Chief Medical Officer Elissa Joy Charbonneau had 369 shares of Encompass Health common stock withheld at a price of $107.88 per share to cover tax obligations from vesting restricted stock. After this tax-withholding disposition, she directly holds 17,644.061 shares.